- Title
- Improved Durability to SARS-CoV-2 Vaccine Immunity following Coimmunization with Molecular Adjuvant Adenosine Deaminase-1
- Creators
- Gina M Cusimano - Drexel UniversityEbony N Gary - The Wistar InstituteMatthew R Bell - Drexel UniversityBryce M Warner - Public Health Agency of CanadaJennifer Connors - Drexel UniversityNicholas J Tursi - The Wistar InstituteAli R Ali - The Wistar InstituteShiyu Zhang - Drexel UniversityGabriela Canziani - Drexel UniversityBhavani Taramangalam - Drexel UniversityEmma A Gordon - Drexel UniversityIrwin M Chaiken - Drexel UniversitySarah K Wootton - Ontario Veterinary CollegeTrevor Smith - Inovio PharmaceuticalsStephanie Ramos - Inovio PharmaceuticalsDarwyn Kobasa - Public Health Agency of CanadaDavid B Weiner - The Wistar InstituteMichele A Kutzler - Drexel UniversityElias K Haddad - Drexel University
- Publication Details
- The Journal of immunology (1950), v 209(1)
- Publisher
- American Association of Immunologists (AAI)
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Biochemistry and Molecular Biology; Microbiology and Immunology; Medicine (Graduate); Infectious Diseases (and HIV Medicine)
- Web of Science ID
- WOS:000823688800012
- Scopus ID
- 2-s2.0-85133214172
- Other Identifier
- 991019168571504721
Journal article
Improved Durability to SARS-CoV-2 Vaccine Immunity following Coimmunization with Molecular Adjuvant Adenosine Deaminase-1
The Journal of immunology (1950), v 209(1)
01 Jul 2022
Featured in Collection : UN Sustainable Development Goals @ Drexel
Metrics
Details
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Collaboration types
- Industry collaboration
- Domestic collaboration
- International collaboration
- Web of Science research areas
- Immunology